Skip to main content

Advertisement

SpringerLink
Log in

Permanent interstitial brachytherapy for prostate cancer: a current review

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Prostate brachytherapy with permanent radioactive implants is becoming an increasingly popular treatment choice for patients with prostate cancer. This therapy is attractive to patients due to the fact that it is an outpatient procedure and in many cases has been associated with lower long-term risks of urinary incontinence and erectile dysfunction when compared to other curative modalities. This review will describe the history, isotopes used, implantation techniques, and results achieved with modern prostate brachytherapy. Results will be discussed both in terms of cancer control and health-related quality of life endpoints.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hall JD, Boyd JC, Lippert MC, Theodorescu D (2003) Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology 61:402–407

    Article  PubMed  Google Scholar 

  2. Pasteau D (1913) The radium treatment of cancer of the prostate. Arch Roentgenol Ray 28:396

    Google Scholar 

  3. Flocks R, Kerr H, Elkins H, Mador D (1959) The treatment of carcinoma of the prostate by interstitial radiation with radioactive gold: a follow-up report. J Urol 71:628–633

    Google Scholar 

  4. Whitmore WF Jr, Hilaris B, Grabstald H (1972) Retropubic implantation to iodine 125 in the treatment of prostatic cancer. J Urol 108:918–920

    PubMed  Google Scholar 

  5. Zelefsky MJ, Whitmore WF Jr (1997) Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. J Urol 158:23–29; discussion 29–30

    CAS  PubMed  Google Scholar 

  6. Watanabe H, Igari D, Tanahashi Y, Harada K, Saitoh M (1975) Transrectal ultrasonotomography of the prostate. J Urol 114:734–739

    CAS  PubMed  Google Scholar 

  7. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I (1983) Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130:283–286

    CAS  PubMed  Google Scholar 

  8. Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y (2000) The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46:221–230

    Article  CAS  PubMed  Google Scholar 

  9. Blasko JC, Grimm PD, Sylvester JE, Badiozamani KR, Hoak D, Cavanagh W (2000) Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46:839–850

    Article  CAS  PubMed  Google Scholar 

  10. Langley SE, Laing R (2002) Prostate brachytherapy has come of age: a review of the technique and results. BJU Int 89:241–249

    Article  CAS  PubMed  Google Scholar 

  11. Ling CC (1992) Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model. Int J Radiat Oncol Biol Phys 23:81–87

    CAS  PubMed  Google Scholar 

  12. Nag S, Scaperoth DD, Badalament R, Hall SA, Burgers J (1995) Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. Urology 45:87–92

    CAS  PubMed  Google Scholar 

  13. Beyer DC, Priestley JB Jr (1997) Biochemical disease-free survival following 125I prostate implantation. Int J Radiat Oncol Biol Phys 37:559–563

    Article  CAS  PubMed  Google Scholar 

  14. Blasko JC, Wallner K, Grimm PD, Ragde H (1995) Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. J Urol 154:1096–1099

    CAS  PubMed  Google Scholar 

  15. Dattoli M, Wallner K, Sorace R, Koval J, Cash J, Acosta R, Brown C, Etheridge J, Binder M, Brunelle R, Kirwan N, Sanchez S, Stein D, Wasserman S (1996) 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma (see comments). Int J Radiat Oncol Biol Phys 35:875–879

    Article  CAS  PubMed  Google Scholar 

  16. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester J, Hoak DC, Cavanagh W, Landin K (1997) Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up [published erratum appears in (1998) Semin Surg Oncol 14:185]. Semin Surg Oncol 13:438–443

    Article  CAS  PubMed  Google Scholar 

  17. Cha CM, Potters L, Ashley R, Freeman K, Wang XH, Waldbaum R, Leibel S (1999) Isotope selection for patients undergoing prostate brachytherapy. Int J Radiat Oncol Biol Phys 45:391–395

    Article  CAS  PubMed  Google Scholar 

  18. Vicini FA, Vargas C, Edmundson G, Kestin L, Martinez A (2003) The role of high-dose rate brachytherapy in locally advanced prostate cancer. Semin Radiat Oncol 13:98–108

    Article  PubMed  Google Scholar 

  19. Stone NN, Stock RG (2000) Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetric analysis of implant quality. Int J Radiat Oncol Biol Phys 46:1199–1204

    Article  CAS  PubMed  Google Scholar 

  20. Krupski T, Bissonette EA, Petroni GR, Theodorescu D (2003) The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy. Eur Urol 43:467–472

    Article  PubMed  Google Scholar 

  21. Terk MD, Stock RG, Stone NN (1998) Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160:1379–1382

    CAS  PubMed  Google Scholar 

  22. Merrick GS, Butler WM, Wallner KE, Lief JH, Galbreath RW (2002) Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology 60:650–655

    Article  PubMed  Google Scholar 

  23. Hughes S, Wallner K, Merrick G, Miller S, True LD (2001) Preexisting histologic evidence of prostatitis is unrelated to postimplant urinary morbidity. Int J Cancer 96 [Suppl]:79–82

    Google Scholar 

  24. Wallner K, Lee H, Wasserman S, Dattoli M (1997) Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Int J Radiat Oncol Biol Phys, 37:565–569

    Google Scholar 

  25. Stone NN, Ratnow ER, Stock RG (2000) Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation. Tech Urol 6:123–127

    CAS  PubMed  Google Scholar 

  26. Krupski T, Petroni GR, Bissonette EA, Theodorescu D (2000) Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 55:736–742

    Article  CAS  PubMed  Google Scholar 

  27. Nag S, Beyer D, Friedland J, Grimm P, Nath R (1999) American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44:789–799

    Article  CAS  PubMed  Google Scholar 

  28. Grann A, Gaudin PB, Raben A, Wallner K (1998) Pathologic features from prostate needle biopsy and prognosis after I-125 brachytherapy. Radiat Oncol Investig 6:170–174

    Article  CAS  PubMed  Google Scholar 

  29. Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E (2002) Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland. Int J Radiat Oncol Biol Phys 52:664–673

    Article  PubMed  Google Scholar 

  30. Kestin LL, Goldstein NS, Vicini FA, Martinez AA (2002) Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy. J Urol 168:1994–1999

    CAS  PubMed  Google Scholar 

  31. Nag S, Ciezki JP, Cormack R, Doggett S, DeWyngaert K, Edmundson GK, Stock RG, Stone NN, Yu Y, Zelefsky MJ (2001) Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 51:1422–1430

    Article  CAS  PubMed  Google Scholar 

  32. Grimm P, Blasko J, Ragde H (1994) Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for treatment of early stage prostate cancer. Technical concepts in planning, operative technique, and evaluation. Urol Clin North Am 2:113–125

    Google Scholar 

  33. Kucway R, Vicini F, Huang R, Stromberg J, Gonzalez J, Martinez A (2002) Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol 167:2443–2447

    CAS  PubMed  Google Scholar 

  34. Stock RG, Stone NN, Wesson MF, DeWyngaert JK (1995) A modified technique allowing interactive ultrasound-guided three- dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32:219–225

    Article  CAS  PubMed  Google Scholar 

  35. Shanahan TG, Nanavati PJ, Mueller PW, Maxey RB (2002) A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys 53:490–496

    Article  PubMed  Google Scholar 

  36. Koutrouvelis PG (1998) Three-dimensional stereotactic posterior ischiorectal space computerized tomography guided brachytherapy of prostate cancer: a preliminary report. J Urol 159:142–145

    CAS  PubMed  Google Scholar 

  37. Brown D, Colonias A, Miller R, Benoit R, Cohen J, Arshoun Y, Galloway M, Karlovits S, Wu A, Johnson M, Quinn A, Kalnicki S (2000) Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation. Int J Radiat Oncol Biol Phys 47:353–360

    Article  CAS  PubMed  Google Scholar 

  38. Biggs PJ, Kelley DM (1983) Geometric reconstruction of seed implants using a three-film technique. Med Phys 10:701–704

    Article  CAS  PubMed  Google Scholar 

  39. Roy JN, Wallner KE, Harrington PJ, Ling CC, Anderson LL (1993) A CT-based evaluation method for permanent implants: application to prostate. Int J Radiat Oncol Biol Phys 26:163–169

    CAS  PubMed  Google Scholar 

  40. Lee WR, Roach M 3rd, Michalski J, Moran B, Beyer D (2002) Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys 54:457–461

    Article  PubMed  Google Scholar 

  41. Willins J, Wallner K (1997) CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 39:347–353

    Article  CAS  PubMed  Google Scholar 

  42. Moerland MA, Wijrdeman HK, Beersma R, Bakker CJ, Battermann JJ (1997) Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 37:927–933

    Article  CAS  PubMed  Google Scholar 

  43. Dubois DF, Prestidge BR, Hotchkiss LA, Bice WS Jr, Prete JJ (1997) Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39:1037–1041

    Article  CAS  PubMed  Google Scholar 

  44. Hurwitz MD, Cormack R, Tempany CM, Kumar S, D'Amico AV (2000) Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer. Tech Urol 6:89–94

    CAS  PubMed  Google Scholar 

  45. D'Amico A, Cormack R, Kumar S, Tempany CM (2000) Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol 14:367–370

    CAS  PubMed  Google Scholar 

  46. D'Amico AV, Tempany CM, Cormack R, Hata N, Jinzaki M, Tuncali K, Weinstein M, Richie JP (2000) Transperineal magnetic resonance image guided prostate biopsy. J Urol 164:385–387

    CAS  PubMed  Google Scholar 

  47. Cormack RA, Kooy H, Tempany CM, D'Amico AV (2000) A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 46:207–214

    Article  CAS  PubMed  Google Scholar 

  48. Yue N, Chen Z, Peschel R, Dicker AP, Waterman FM, Nath R (1999) Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants. Int J Radiat Oncol Biol Phys 45:1063–1072

    Article  CAS  PubMed  Google Scholar 

  49. Yue N, Dicker AP, Corn BW, Nath R, Waterman FM (1999) A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate. Int J Radiat Oncol Biol Phys 43:447–454

    Article  CAS  PubMed  Google Scholar 

  50. Yue N, Dicker AP, Nath R, Waterman FM (1999) The impact of edema on planning 125I and 103Pd prostate implants. Med Phys 26:763–767

    Article  CAS  PubMed  Google Scholar 

  51. Waterman FM, Yue N, Corn BW, Dicker AP (1998) Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 41:1069–1077

    Article  CAS  PubMed  Google Scholar 

  52. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH (2003) Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 56:454–461

    Article  PubMed  Google Scholar 

  53. Van Gellekom MP, Moerland MA, Kal HB, Battermann JJ (2002) Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema. Int J Radiat Oncol Biol Phys 53:422–433

    PubMed  Google Scholar 

  54. Storey MR, Landgren RC, Cottone JL, Stallings JW, Logan CW, Fraiser LP, Ross CS, Kock RJ, Berkley LW, Hauer-Jensen M (1999) Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys 43:565–570

    Article  CAS  PubMed  Google Scholar 

  55. Ramos CG, Carvalhal GF, Smith DS, Mager DE, Catalona WJ (1999) Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer. J Urol 161:1212–1215

    CAS  PubMed  Google Scholar 

  56. Ragde H, Elgamal AA, Snow PB, Brandt J, Bartolucci AA, Nadir BS, Korb LJ (1998) Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 83:989–1001

    Article  PubMed  Google Scholar 

  57. Ragde H, Korb LJ, Elgamal AA, Grado GL, Nadir BS (2000) Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 89:135–141

    CAS  PubMed  Google Scholar 

  58. Blasko JC, Grimm PD, Sylsvester JE, Cavanagh W (2000) The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 57:273–278

    Article  CAS  PubMed  Google Scholar 

  59. Merrick GS, Butler WM, Lief JH, Galbreath RW, Adamovich E (2002) Biochemical outcome for hormone-naive patients with high-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external-beam radiation. Cancer J 8:322–327

    PubMed  Google Scholar 

  60. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer (see comments). JAMA 280:969–974

    Article  CAS  PubMed  Google Scholar 

  61. Dattoli M, Wallner K, True L, Sorace R, Koval J, Cash J, Acosta R, Biswas M, Binder M, Sullivan B, Lastarria E, Kirwan N, Stein D (1999) Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma. Int J Radiat Oncol Biol Phys 45:853–856

    Article  CAS  PubMed  Google Scholar 

  62. Grado GL, Larson TR, Balch CS, Grado MM, Collins JM, Kriegshauser JS, Swanson GP, Navickis RJ, Wilkes MM (1998) Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys 42:289–298

    Article  CAS  PubMed  Google Scholar 

  63. D'Amico AV (2002) Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer. Urology 60:32–37; discussion 37–38

    Article  PubMed  Google Scholar 

  64. Pilepich MV, Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P, et al. (1995) Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45:616–623

    Article  CAS  PubMed  Google Scholar 

  65. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295–300

    Google Scholar 

  66. Coblentz TR, Bissonette EA, Williams KR, Theodorescu D (2002) Multimodality radiotherapy and androgen ablation in the treatment of clinically localized prostate cancer: early results in high risk patients. Prostate Cancer Prostatic Dis 5:219–225

    Article  CAS  PubMed  Google Scholar 

  67. Cox J, Grignon D, Kaplan R (1997) Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035–1041

    Article  PubMed  Google Scholar 

  68. Desai J, Stock RG, Stone NN, Iannuzzi C, DeWyngaert JK (1998) Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Investig 6:135–141

    Article  CAS  PubMed  Google Scholar 

  69. Brown D, Colonias A, Miller R, Benoit R, Cohen J, Arshoun Y, Galloway M, Karlovits S, Wu A, Johnson M, Quinn A, Kalnicki S (2000) Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation. Int J Radiat Oncol Biol Phys 47:353–360

    Article  CAS  PubMed  Google Scholar 

  70. Terk MD, Stock RG, Stone NN (1998) Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160:1379–1382

    CAS  PubMed  Google Scholar 

  71. Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S (1999) Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45:59–67

    Article  CAS  PubMed  Google Scholar 

  72. Elshaikh MA, Angermeier K, Ulchaker JC, Klein EA, Chidel MA, Mahoney S, Wilkinson DA, Reddy CA, Ciezki JP (2003) Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy. Urology 61:152–155

    Article  PubMed  Google Scholar 

  73. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Murray B, Zeroski D, Lief JH (2003) Dysuria after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 55:979–985

    Article  PubMed  Google Scholar 

  74. Arterbery VE, Frazier A, Dalmia P, Siefer J, Lutz M, Porter A (1997) Quality of life after permanent prostate implant. Semin Surg Oncol 13:461–464

    Article  CAS  PubMed  Google Scholar 

  75. Fulmer BR, Bissonette EA, Petroni GR, Theodorescu D (2001) Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy. Cancer 91:2046–2055

    Article  CAS  PubMed  Google Scholar 

  76. Brandeis JM, Litwin MS, Burnison CM, Reiter RE (2000) Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163:851–857

    CAS  PubMed  Google Scholar 

  77. Egawa S, Shimura S, Irie A, Kitano M, Nishiguchi I, Kuwao S, Hayakawa K, Baba S (2001) Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer. Jpn J Clin Oncol 31:541–547

    Article  CAS  PubMed  Google Scholar 

  78. Beyer D, Nath R, Butler W, Merrick G, Blasko J, Nag S, Orton C (2000) American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 47:273–275

    Article  CAS  PubMed  Google Scholar 

  79. Merrick GS, Butler WM, Wallner KE, Lief JH, Galbreath RW (2002) Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology 60:650–655

    Article  PubMed  Google Scholar 

  80. Wallner K, Lee H, Wasserman S, Dattoli M (1997) Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Int J Radiat Oncol Biol Phys 37:565–569

    Article  CAS  PubMed  Google Scholar 

  81. Zelefsky MJ, Hollister T, Raben A, Matthews S, Wallner KE (2000) Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47:1261–1266

    Article  CAS  PubMed  Google Scholar 

  82. Keetch DW, Andriole GL, Catalona WJ (1994) Complications of radical retropubic prostatectomy. AUA Update Series 13

  83. Catalona WJ, Ramos CG, Carvalhal GF (1999) Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin 49:282–296

    CAS  PubMed  Google Scholar 

  84. Walsh PC, Marschke P, Ricker D, Burnett AL (2000) Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55:58–61

    Article  CAS  Google Scholar 

  85. DiBiase SJ, Wallner K, Tralins K, Sutlief S (2000) Brachytherapy radiation doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys 46:1301–1307

    Article  CAS  PubMed  Google Scholar 

  86. Fisch BM, Pickett B, Weinberg V, Roach M (2001) Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology 57:955–959

    Article  CAS  PubMed  Google Scholar 

  87. Merrick GS, Wallner K, Butler WM, Lief JH, Sutlief S (2001) Short-term sexual function after prostate brachytherapy. Int J Cancer 96:313–319

    Article  CAS  PubMed  Google Scholar 

  88. Ravery V (2001) Brachytherapy versus radical prostatectomy. BJU Int 87:141–143

    Article  CAS  PubMed  Google Scholar 

  89. Valicenti RK, Bissonette EA, Chen C, Theodorescu D (2002) Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol 168:2499–2504; discussion 2504

    PubMed  Google Scholar 

  90. Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, Grann A, Gaudin P, Fuks Z, Leibel SA (1999) Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17:517–522

    CAS  PubMed  Google Scholar 

  91. Stock RG, Kao J, Stone NN (2001) Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165:436–439

    CAS  PubMed  Google Scholar 

  92. Merrick GS, Butler WM, Dorsey AT, Lief JH, Donzella JG (2000) A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 48:1069–1074

    Article  CAS  PubMed  Google Scholar 

  93. Hollenbeck BK, Dunn RL, Wei JT, McLaughlin PW, Han M, Sanda MG (2002) Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy. Urology 59:480–484

    Article  PubMed  Google Scholar 

  94. Miller NL, Bissonette EA, Bahnson R, Wilson J, Theodorescu D (2003) Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy. Cancer 97:1203–1210

    Article  CAS  PubMed  Google Scholar 

  95. Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW (2001) Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50:1235–1242

    Article  CAS  PubMed  Google Scholar 

  96. Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH (2002) Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 52:893–902

    Article  PubMed  Google Scholar 

  97. Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20:557–566

    Article  PubMed  Google Scholar 

  98. Neerhut GJ, Wheeler T, Cantini M, Scardino PT (1988) Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate. J Urol 140:544–549

    CAS  PubMed  Google Scholar 

  99. Ghafar MA, Johnson CW, De La Taille A, Benson MC, Bagiella E, Fatal M, Olsson CA, Katz AE (2001) Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 166:1333–1337; discussion 1337–1338

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Virginia Health Sciences Center, Box 422, Charlottesville, VA 22908, USA

    Jeffrey Woolsey, Nicole Miller & Dan Theodorescu

  2. Department of Molecular Physiology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA

    Dan Theodorescu

Authors
  1. Jeffrey Woolsey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicole Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dan Theodorescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dan Theodorescu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woolsey, J., Miller, N. & Theodorescu, D. Permanent interstitial brachytherapy for prostate cancer: a current review. World J Urol 21, 209–219 (2003). https://doi.org/10.1007/s00345-003-0357-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-003-0357-9

Keywords

Search

Navigation